Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SELL | P14151 | 1/20 | 0.35 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
| ▸ | SELE | P16581 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15676352 | 0.91 | IGF1R (0.33) | ALDH1A1SELLSELPSELEACHE | |
| SCHEMBL70689 | 0.91 | ALOX5 (0.35) | ALDH1A1SELLSELPSELEACHE | |
| SCHEMBL10014867 | 0.89 | ALDH1A1 (0.35) | ALDH1A1SELLSELPSELEACHE | |
| Durohydroquinone SCHEMBL69786 | 0.89 | ALOX5 (0.38) | ALDH1A1SELLSELPSELEACHE | |
| SCHEMBL7559713 | 0.84 | IGF1R (0.35) | ALDH1A1SELLSELPSELEACHE | |
| SCHEMBL397768 | 0.84 | ALOX5 (0.36) | ALDH1A1SELLSELPSELEACHE | |
| SCHEMBL10828845 | 0.80 | — | — | |
| Phloroglucinol SCHEMBL20494508 | 0.80 | BACE1 (0.57) | ALDH1A1SELLSELPSELEACHE | |
| SCHEMBL13964608 | 0.80 | ALDH1A1 (0.46) | ALDH1A1CA1CA2TP53CYP1A2 | |
| SCHEMBL2798555 | 0.78 | TDP1 (0.39) | ALDH1A1ACHEALOX5TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 519 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121103161-B | Preparation of COF-polyamide hybrid nanofiltration membrane and wastewater treatment application | 华北电力大学（保定） | 2026-05-12 | — | — | CN | claimed |
| CN-121775689-B | Preparation method for constructing strong interlayer bonding nanofiltration membrane through solid-liquid interfacial polymerization, product and application thereof | 上海工程技术大学 | 2026-05-12 | — | — | CN | claimed |
| CN-121574323-A | Dibenzothiophene sulfonyl covalent organic framework material and application thereof in thiadiazole and derivative photocatalytic synthesis | 三峡大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250367137-A1 | Phloroglucinol Formulations And Methods Of Use | CINPHLORO PHARMA LLC (US) | 2025-12-04 | — | — | US | claimed |
| EP-4621488-A1 | RINSE SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMATION METHOD USING SAME | Ycchem Co., Ltd. (KR) | 2025-09-24 | — | — | EP | claimed |
| US-20250236813-A1 | RINSE SOLUTION COMPOSITION FOR EXTREME ULTRAVIOLET PHOTOLITHOGRAPHY AND PATTERN FORMATION METHOD USING SAME | YCCHEM CO., LTD. (KR) | 2025-07-24 | — | — | US | claimed |
| CN-120137125-A | Natural rubber composite material based on polymer COFs material and preparation method thereof | 青岛黑猫新材料研究院有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250177320-A1 | PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | CINRX PHARMA, LLC (US) | 2025-06-05 | — | — | US | claimed |
| CN-120059097-A | Magnetic carboxylation covalent organic framework and preparation method and application thereof | 长沙理工大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120064530-A | Application of magnetic solid-phase dispersion extractant in detection of mycotoxin content in wheat | 南昌大学 | 2025-05-30 | — | — | CN | claimed |
| CN-112535659-A | Preparation method of phloroglucinol injection | 南京艾德凯腾生物医药有限责任公司 | 2021-03-23 | — | — | CN | claimed |
| CN-112516077-A | Phloroglucinol injection and preparation method thereof | 万邦德制药集团有限公司 | 2021-03-19 | — | — | CN | claimed |
| CN-111840259-A | Injection of phloroglucinol and trimethyl phloroglucinol and preparation method thereof | 武汉人福药业有限责任公司 | 2020-10-30 | — | — | CN | claimed |
| WO-2018165404-A1 | PHARMACEUTICAL FORMUALTIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | CINRX PHARMA, LLC (US) | 2018-09-13 | — | — | WO | claimed |
| US-20150150953-A1 | PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE | POSI VISIONARY SOLUTIONS LLP (GB) | 2015-06-04 | — | — | US | claimed |
| EP-2790689-A1 | TREATMENT OF MIGRAINE HEADACHES, IN PARTICULAR CLUSTER HEADACHES | Pharmeuro (LU) | 2014-10-22 | — | — | EP | claimed |
| US-20130344145-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | POSI VISIONARY SOLUTIONS LLP (GB) | 2013-12-26 | — | — | US | claimed |
| EP-2641968-A2 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND -D-GALACTOSIDASE | Posi Visionary Solutions LLP (GB) | 2013-09-25 | — | — | EP | claimed |
| EP-2641598-A2 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | Posi Visionary Solutions LLP (GB) | 2013-09-25 | — | — | EP | claimed |
| WO-2013087410-A1 | TREATMENT OF MIGRAINE HEADACHES, IN PARTICULAR CLUSTER HEADACHES | PHARMEURO (LU) | 2013-06-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367137-A1 | Phloroglucinol Formulations And Methods Of Use | MLN, HRH2, PYGM | ALDH1A1 4265/4885SELL 2521/4885SELP 3372/4885 |
| US-20250177320-A1 | PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | SLC5A2, SLC5A1, LCT | ALDH1A1 4469/4885SELL 696/4885SELP 653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.